ELS-tíðindi - júní 2001

50 ELS tíðindi 6/01
(21) 5840
(22) 5.2.2001
(41) 5.2.2001
(51) C07D 263/32; C07D 277/24; A61K
31/421; A61K 31/426; C07D 413/12;
C07D 417/12; A61K 31/422; A61K
31/427
(54) Setnar oxazól og þíazól afleiður sem
hPPAR gamma og hPPAR alfa
hvatar.
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex, UB6 ONN,
Bretlandi.
(72) Jon Loren Collins, Research Triangle
Park; Timothy Mark Willson, Research
Triangle Park; Jeffrey Alan Oplinger,
Research Triangle Park; Milana
Duzube, Chapel Hill; North Carolina,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 7.8.98, GB, 9817118.4
(85) 5.2.2001
(86) 5.8.99, PCT/EP99/05666
(21) 5843
(22) 9.2.2001
(41) 9.2.2001
(51) C07D 473/06; A61K 31/522
(54) Fenýl janþín (yanthine) afleiður.
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex, UB6 0NN,
Bretlandi.
(72) Susan Mary Daluge; Cynthia Holder
Jurgensen; Michael Tolar Martin;
Martin Howard Osterhout; Research
Triangle Park, North Carolina,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 13.8.98, GB, 9817623.3
(85) 9.2.2001
(86) 11.8.99, PCT/EP99/05814
(21) 5848
(22) 16.2.2001
(41) 16.2.2001
(51) A61K 38/00
(54) Aðferð til að stilla T-frumur sem eru
svarar og samsetningu þeirra.
(71) Biogen, Inc., 14 Cambridge Center,
Cambridge, Massachusetts 02142,
Bandaríkjunum.
(72) Daniel Magilavy, Cambridge,
Massachusetts, Bandaríkjunum.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Skeifunni 7, 108 Reykjavík.
(30) 31.8.98, US, 60/098,456
(85) 16.2.2001
(86) 31.8.99, PCT/US99/20026
(21) 5849
(22) 16.2.2001
(41) 16.2.2001
(51) C07D 213/42; C07D 239/42; C07D
295/22; C07D 213/74; C07D 417/12;
C07D 401/12; C07D 215/12; C07D
333/20; C07D 241/12; A61K 31/44;
A61K 31/495
(54) Arýlpíperazín og notkun þeirra sem
málmprótínasa bælandi miðlar
(MMP).
(71) AstraZeneca AB, S-151 85 Södertälje,
Svíþjóð.
(72) Bernard Christophe Barlaam,
Wilmington, Delaware, Bandaríkjunum;
Nicholas John Newcombe,
Macclesfield, Cheshire, Bretlandi;
Howard Tucker, Macclesfield,
Cheshire, Bretlandi; David Waterson,
Macclesfield, Cheshire, Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 31.8.98, EP, 98402144.4
4.6.99, EP, 99401351.4
(85) 16.2.2001
(86) 25.8.99, PCT/GB99/02801
(21) 5850
(22) 16.2.2001
(41) 16.2.2001
(51) A23L 1/30; A23L 1/302; A61K 31/385
(54) Andoxunar samsetning sem
samanstendur af asetýl L-karnitíni og
alfa-lípósýru.
(71) Sigma-Tau Healthscience S.P.A.,
Via Treviso, 4, I-00040 Pomezia,
Ítalíu.
(72) Claudio Cavazza, Roma, Ítalíu.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 1.9.98, IT, RM98A000566
(85) 16.2.2001
(86) 19.8.99, PCT/IT99/00268
(21) 5852
(22) 20.2.2001
(41) 20.2.2001
(51) A61K 31/505; A61P 25/16
(54) Lyfjamiðlar til meðhöndlunar á
parkinsonsveiki ADHD og smákirtilsæxlum.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Elisa Rose Jackson, Norwich;
Stafford McLean, Stonington; Stevin
Howard Zorn, North Stonington;
Connecticut, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 21.9.98, US, 60/101,191
12.10.98, US, 60/103,868
(85) 20.2.2001
(86) 3.9.99, PCT/IB99/01503
(21) 5856
(22) 23.2.2001
(41) 23.2.2001
(51) A61K 38/17; A61K 39/395
(54) Aðferðir þar sem integrín-mótlyf eru
notuð til að meðhöndla margföld
mergæxli og uppsog í bein af völdum
mergæxla.
(71) Board of Regents, the University
of Texas system, 201 West 71st
Street, Austin, Texas 78701,
Bandaríkjunum.
(72) Gregory R. Mundy; Toshiyuki
Yoneda; San Antonio, Texas,
Bandaríkjunum.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Skeifunni 7, 108 Reykjavík.
(30) 14.9.98, US, 60/100,182
(85) 23.2.2001
(86) 13.9.99, PCT/US99/21170
(21) 5857
(22) 23.2.2001
(41) 23.2.2001
(51) A22C 25/16
(54) Aðferð til flökunar á fiski og
flökunarvél til notkunar við flökunina.
(71) Arne K. Nordstrand, N-6050
Valderøy, Noregi.
(72) Arne K. Nordstrand, Valderøy,
Noregi.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Skeifunni 7, 108 Reykjavík.
(30) 24.8.98, NO, 19983885
(85) 23.2.2001
(86) 23.8.99, PCT/NO99/00263
(21) 5858
(22) 23.2.2001
(41) 23.2.2001
(51) C07D 215/42; A61K 31/47; C07D
221/16; C07D 215/46; C07D 417/12;
C07D 413/12
(54) 4-amínó setinn-2-setinn-1, 2, 3, 4tetrahýdrókínólín
sem CETP latar.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Michael Paul DeNinno, Gales Ferry;
George Tetteh Magnus-Aryitey,
Ledyard; Roger Benjamin Ruggeri,
Waterford; Ronald Thure Wester,
Ledyard; Connecticut, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 17.9.98, US, 60/100,927
(85) 23.2.2001
(86) 10.9.99, PCT/IB99/01534